shingles

Photo
11.10.2023 • News

GSK and Zhifei Co-Promote Shingles Vaccine in China

GSK has struck a deal with Chongqing Zhifei Biological Products to promote the British group's shingles vaccine, Shingrix, in China for an initial three-year period. Starting on Jan.1, 2024, Zhifei will have exclusive rights to import and distribute Shingrix in China through its service network of more than 30,000 vaccination points across the country.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.